GARLANDA, CECILIA
 Distribuzione geografica
Continente #
NA - Nord America 7.109
EU - Europa 1.440
AS - Asia 806
AF - Africa 275
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 6
Totale 9.661
Nazione #
US - Stati Uniti d'America 7.077
SG - Singapore 395
FI - Finlandia 394
CN - Cina 325
NG - Nigeria 274
IE - Irlanda 270
IT - Italia 212
FR - Francia 146
DE - Germania 116
GB - Regno Unito 73
NL - Olanda 73
SE - Svezia 67
BE - Belgio 45
IN - India 32
CA - Canada 31
IL - Israele 16
RU - Federazione Russa 15
CL - Cile 12
TR - Turchia 12
UA - Ucraina 7
JP - Giappone 6
EU - Europa 5
IR - Iran 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BR - Brasile 4
AU - Australia 3
ES - Italia 3
NZ - Nuova Zelanda 3
RO - Romania 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
CH - Svizzera 2
HK - Hong Kong 2
LT - Lituania 2
MN - Mongolia 2
NO - Norvegia 2
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
IQ - Iraq 1
KR - Corea 1
MK - Macedonia 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
SC - Seychelles 1
Totale 9.661
Città #
Wilmington 1.424
Chandler 1.418
San Mateo 463
Ann Arbor 444
Helsinki 393
Singapore 282
Shanghai 280
Benin City 274
Dublin 269
Boardman 254
Lawrence 246
Princeton 246
Leawood 241
Ashburn 157
New York 141
Paris 136
Woodbridge 130
Fairfield 121
Amsterdam 71
London 57
Milan 56
Seattle 47
Brussels 44
Norwalk 40
San Diego 39
Abbiategrasso 33
Falls Church 26
Los Angeles 22
Toronto 22
Phoenix 20
Andover 17
Pune 17
Santa Clara 17
Falkenstein 15
Kocaeli 11
Redmond 11
Beijing 10
Redwood City 10
Rome 10
Munich 9
Clearwater 8
Houston 8
Winnipeg 8
Pavia 7
Des Moines 6
Mandello del Lario 6
Cambridge 5
Frankfurt am Main 5
Hefei 5
Monmouth Junction 5
Montreuil 5
Moscow 5
Bari 4
Guangzhou 4
Hanover 4
Pisa 4
Sacramento 4
Belford Roxo 3
Caserta 3
Cologno Monzese 3
Croydon 3
Haifa 3
Melbourne 3
San Jose 3
Atlanta 2
Berlin 2
Buffalo 2
Busnago 2
Cupertino 2
Dallas 2
Delhi 2
Evanston 2
Genoa 2
Henderson 2
La Spezia 2
Las Vegas 2
Leiden 2
Macherio 2
Mumbai 2
Novokuznetsk 2
Oslo 2
Palazzolo sull'Oglio 2
Parabita 2
Raleigh 2
Taipei 2
Tappahannock 2
Tokyo 2
Trezzo sull'Adda 2
Triggiano 2
Ulaanbaatar 2
Vercelli 2
Wellington 2
Wuhan 2
Yerevan 2
Zanjan 2
Athens 1
Athlone 1
Augusta 1
Beersheba 1
Bengaluru 1
Totale 7.704
Nome #
Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppression 122
Pentraxins in the activation and regulation of innate immunity 76
Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors 74
Characterization of MEC 14.7, a new monoclonal antibody recognizing mouse CD34: a useful reage for identifying and characterizing blood vessels and hematopoietic precursors. 73
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 68
Occurrence and significance of tumor - Associated neutrophils in patients with colorectal cancer 66
Negative regulatory receptors of the IL-1 family 63
The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling 63
Evolution of the pentraxin family: the new entry PTX4. 62
Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation 62
Lack of IL-1R8 in neurons causes hyperactivation of IL-1 receptor pathway and induces MECP2-dependent synaptic defects. 62
Anti-tumor activity of cytokines against opportunistic vascular tumors in mice. 60
Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells. 59
Humoral innate immunity at the crossroad between microbe and matrix recognition: The role of PTX3 in tissue damage 59
An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode 59
Neutrophils in innate and adaptive immunity 59
Macrophage diversity and polarization in atherosclerosis: a question of balance. 58
The Interleukin-1 Family 57
Purification through affinity chromatography and microsequencing 57
The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease 56
Macrophage control of inflammation: Negative pathways of regulation of inflammatory cytokines 56
Interplay between Myeloid Cells and Humoral Innate Immunity 56
The "sweet" side of a long pentraxin: how glycosylation affects PTX3 functions in innate immunity and inflammation 55
IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity 55
The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling. 54
TIR8/SIGIRR is an interleukin-1 receptor/toll like receptor family member with regulatory functions in inflammation and immunity 54
DIAGNOSTIC TEST FOR INFLAMMATORY ENDOTHELIAL DYSFUNCTIONS IN PREGNANCIES 54
Cigarette smoke induces PTX3 expression in pulmonary veins of mice in an IL-1 dependent manner. 54
Fluid phase recognition molecules in neutrophil-dependent immune responses 54
IL-1 and IL-1 regulatory pathways in cancer progression and therapy 53
Pentraxins in humoral innate immunity. 53
Long Pentraxin 3/Tumor Necrosis Factor-Stimulated Gene-6 Interaction A Biological Rheostat for Fibroblast Growth Factor 2-Mediated Angiogenesis 53
An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development. 53
Response of CFTR-Deficient Mice to Long-Term chronic Pseudomonas aeruginosa Infection and PTX3 Therapy 52
Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. 52
Regulation of leukocyte recruitment by the long pentraxin PTX3. 52
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. 52
The Humoral Pattern Recognition Molecule PTX3 Is a Key Component of Innate Immunity against Urinary Tract Infection 51
Tumor associated macrophages and neutrophils in tumor progression. 51
Complement as a target in COVID-19? 51
Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells. 50
Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation 50
Clearance of Cell Remnants and Regeneration of Injured Muscle Depend on Soluble Pattern Recognition Receptor PTX3 50
Damping Excessive Inflammation and Tissue Damage in Mycobacterium tuberculosis Infection by Toll IL-1 Receptor 8/Single Ig IL-1-Related Receptor, a Negative Regulator of IL-1/TLR Signaling 50
Nonredundant role of CCRL2 in lung dendritic cell trafficking. 50
Heterogeneity of Endothelial Cells: specific markers 49
Interactions of the humoral pattern recognition molecule PTX3 with the complement system 49
Absence of Toll-IL-1 Receptor 8/Single Immunoglobulin IL-1 Receptor-Related Molecule Reduces House Dust Mite-Induced Allergic Airway Inflammation in Mice 49
Pentraxin 3 regulates synaptic function by inducing AMPA receptor clustering via ECM remodeling and β1-integrin 49
ENDOGENOUS PENTRAXIN 3 INHIBITS NEPHROCALCINOSIS AND PROTECTS FROM HYPEROXALURIA-INDUCED CHRONIC KIDNEY DISEASE 49
A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. 49
Cytokine regulation of endothelial cells 49
Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation 49
Pentraxins in innate immunity: lessons from PTX3. 48
Molecular pathways and targets in cancer-related inflammation. 48
The yin-yang of the interaction between myelomonocytic cells and NK cells 48
The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. 48
Gene and Protein Expression in Response to Different Growth Temperatures and Oxygen Availability in Burkholderia thailandensis 48
Glucose availability enhances lipopolysaccharide production and immunogenicity in the opportunistic pathogen Acinetobacter baumannii 47
Chorionic gonadotropin up-regulates long pentraxin 3 expression in myeloid cells. 47
Mesenchymal Stromal Cell-Derived PTX3 Promotes Wound Healing via Fibrin Remodeling 47
Toll-like receptor signaling and SIGIRR in renal fibrosis upon unilateral ureteral obstruction. 47
Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. 47
PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization. 47
Antibody against murine PECAM-1 inhibits tumor angiogenesis in mice. 47
MiR-146b Mediates Endotoxin Tolerance in Human Phagocytes 47
PTX3 as a paradigm for the interaction of pentraxins with the Complement system 46
Neutrophils driving unconventional T cells are essential for resistance to sarcomas 46
Novel pathways for negative regulation of inflammatory cytokines centered on receptor expression. 46
The complement system in Aspergillus fumigatus infections and its crosstalk with pentraxins 45
Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. 45
Tumor associated macrophages and neutrophils in cancer 45
Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury 45
Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens. 44
Platelet-macrophage partnership in innate immunity and inflammation 44
Inflammation-mediated promotion of invasion and metastasis. 44
The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice. 44
Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm. 44
Evidence for a DC-specific inhibitory mechanism that depends on MyD88 and SIGIRR. 44
Pentraxins as a key component of innate immunity. 43
Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis. 43
AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch 43
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer 43
PENTRAXIN 3 PLAYS A KEY ROLE IN THE IMMUNOMODULATION OF DIET INDUCED-OBESITY IN MICE 43
Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction. 43
Innate immunity, hemostasis and matrix remodeling: PTX3 as a link 43
Pentraxin 3 mediates neurogenesis and angiogenesis after cerebral ischaemia 43
SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis. 43
An integrated view of humoral innate immunity: pentraxins as a paradigm. 43
Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. 43
The soluble pattern recognition receptor pentraxin-3 in innate immunity, inflammation and fertility. 42
The Long Pentraxin PTX3 as a Key Component of Humoral Innate Immunity and a Candidate Diagnostic for Inflammatory Diseases 42
The Interleukin-1 Family: Back to the Future 42
Decoys and regulatory "receptors" of the IL-1/Toll-like receptor superfamily 42
Pentraxins and atherosclerosis: the role of PTX3. 42
Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity. 42
Pentraxin 3 recruits complement factor H to protect against oxidative stress-induced complement and inflammasome overactivation 42
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients. 42
Inflammatory reaction and implantation: the new entries PTX3 and D6. 41
The immunoproteasome controls the availability of the cardioprotective pattern recognition molecule Pentraxin3 41
Totale 5.111
Categoria #
all - tutte 85.775
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.775


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 0 7
2020/20212.686 34 28 26 20 12 869 448 179 507 316 28 219
2021/20221.295 36 21 14 271 28 13 44 170 195 157 259 87
2022/20233.754 549 135 346 453 371 330 4 292 675 299 238 62
2023/20241.965 199 216 374 89 69 228 128 119 23 46 172 302
2024/2025218 66 49 29 47 27 0 0 0 0 0 0 0
Totale 9.925